Pharma, biotech, devices, and care delivery — listed healthcare ranked by market cap with daily prices and 1-year returns.
| # | Company | Market Cap | Price | 1D | 1Y | QL Signal |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. LLY |
$1.0Tlarge | $1153 | +0.14% | +51.1% | Neutral |
| 2 | Johnson & Johnson JNJ |
$651Blarge | $270 | -0.09% | +55.0% | Underweight |
| 3 | ABBVIE INC. ABBV |
$466Blarge | $264 | -0.02% | +18.9% | Buy |
| 4 | Merck & Co., Inc. MRK |
$362Blarge | $147 | -0.35% | +80.1% | Underweight |
| 5 | Novartis AG NVS |
$267Blarge | $140 | -0.39% | +14.8% | Underweight |
| 6 | AstraZeneca PLC AZN |
$258Blarge | $166 | +0.25% | +7.8% | Buy |
| 7 | Thermo Fisher Scientific, Inc. TMO |
$241Blarge | $651 | -1.10% | +35.4% | Buy |
| 8 | KLA Corporation KLAC |
$231Blarge | $177 | +4.83% | +69.1% | Buy |
| 9 | Amgen Inc AMGN |
$208Blarge | $386 | +1.44% | +39.8% | Neutral |
| 10 | Novo-Nordisk A/S NVO |
$191Blarge | $43.24 | +0.35% | -30.1% | Underweight |
| 11 | Gilead Sciences Inc GILD |
$186Blarge | $150 | -0.26% | +32.1% | Underweight |
| 12 | Abbott Laboratories ABT |
$178Blarge | $103 | +0.37% | -23.7% | Underweight |
| 13 | Pfizer Inc. PFE |
$158Blarge | $27.66 | -0.07% | +14.5% | Neutral |
| 14 | Danaher Corporation DHR |
$149Blarge | $212 | -0.32% | +8.5% | Neutral |
| 15 | Intuitive Surgical Inc. ISRG |
$139Blarge | $393 | +2.62% | -9.7% | Buy |
| 16 | Vertex Pharmaceuticals Inc VRTX |
$129Blarge | $508 | -1.55% | +31.3% | Underweight |
| 17 | Bristol-Myers Squibb Co. BMY |
$129Blarge | $63.06 | +0.28% | +38.3% | Neutral |
| 18 | Medtronic plc MDT |
$118Blarge | $92.13 | -0.69% | -3.6% | Underweight |
| 19 | Stryker Corporation SYK |
$106Blarge | $275 | -1.44% | -27.2% | Underweight |
| 20 | McKesson Corporation MCK |
$102Blarge | $875 | -0.56% | +26.7% | Underweight |
| 21 | Sanofi SNY |
$102Blarge | $42.48 | -1.53% | -10.9% | Underweight |
| 22 | GSK plc GSK |
$101Blarge | $50.22 | -1.88% | +24.6% | Underweight |
| 23 | Trane Technologies plc TT |
$94Blarge | $429 | +1.37% | +6.6% | Underweight |
| 24 | HCA Healthcare, Inc. HCA |
$93Blarge | $428 | -0.31% | +6.6% | Neutral |
| 25 | 3M Company MMM |
$86Blarge | $166 | +0.72% | +6.8% | Underweight |
| 26 | Regeneron Pharmaceuticals Inc REGN |
$81Blarge | $785 | -0.58% | +31.1% | Underweight |
| 27 | Boston Scientific Corp. BSX |
$63Blarge | $43.34 | -0.18% | -55.9% | Underweight |
| 28 | Coherent Corp. COHR |
$62Blarge | $317 | +7.34% | +193.7% | Buy |
| 29 | argenx SE ARGX |
$62Blarge | $990 | -0.55% | +35.3% | Underweight |
| 30 | Moderna, Inc. MRNA |
$61Blarge | $154 | -2.66% | +505.3% | Neutral |
| 31 | Takeda Pharmaceutical Company Limited TAK |
$60Blarge | $18.91 | -0.73% | +25.9% | Neutral |
| 32 | Cencora, Inc. COR |
$59Blarge | $309 | -0.20% | +6.2% | Underweight |
| 33 | Teradyne, Inc. TER |
$58Blarge | $371 | +4.89% | +212.6% | Buy |
| 34 | Keysight Technologies, Inc. KEYS |
$57Blarge | $335 | +1.07% | +89.0% | Buy |
| 35 | Ametek, Inc. AME |
$54Blarge | $238 | +1.42% | +25.9% | Buy |
| 36 | Natera, Inc. NTRA |
$53Blarge | $369 | +0.84% | +105.4% | Buy |
| 37 | Cardinal Health, Inc. CAH |
$52Blarge | $225 | +1.22% | +50.2% | Neutral |
| 38 | Edwards Lifesciences Corp EW |
$51Blarge | $88.26 | +0.01% | +18.4% | Neutral |
| 39 | Becton, Dickinson and Co. BDX |
$49Blarge | $181 | -0.24% | -3.9% | Underweight |
| 40 | Rockwell Automation, Inc. ROK |
$46Blarge | $416 | +1.36% | +19.2% | Neutral |
| 41 | Teva Pharmaceutical Industries Limited TEVA |
$45Blarge | $38.98 | -0.54% | +111.3% | Buy |
| 42 | Agilent Technologies Inc. A |
$44Blarge | $156 | +2.34% | +22.6% | Buy |
| 43 | IQVIA Holdings Inc. IQV |
$44Blarge | $266 | -1.12% | +40.1% | Underweight |
| 44 | Waters Corp WAT |
$41Blarge | $422 | -1.88% | +37.6% | Neutral |
| 45 | Revolution Medicines, Inc. RVMD |
$41Blarge | $191 | -3.26% | +322.3% | Underweight |
| 46 | Idexx Laboratories Inc IDXX |
$40Blarge | $512 | +1.02% | -21.9% | Neutral |
| 47 | BeOne Medicines Ltd. ONC |
$40Blarge | $351 | -0.74% | +2.3% | Underweight |
| 48 | Roper Technologies, Inc. ROP |
$37Blarge | $373 | -0.54% | -26.8% | Underweight |
| 49 | Illumina Inc ILMN |
$36Blarge | $240 | -0.98% | +132.6% | Buy |
| 50 | DexCom, Inc. DXCM |
$34Blarge | $89.35 | +1.90% | +17.9% | Buy |
142 of the top 150 healthcare names by market cap, grouped into 5 clusters on seven daily features — 20-day momentum, RSI, the QL composite, 1-year and 6-month return, size and news sentiment. The layout is a principal-components projection of those features (41.8% + 20.1% of the variance), so distance on the map is similarity in the data, not a drawing. 8 ranked names lacked a feature and are left off rather than imputed. Hover a bubble or a cluster card; click a bubble for the stock page.
| Stock | Cluster | Market cap | 1Y | 20D | RSI | QL Signal |
|---|---|---|---|---|---|---|
| LLY Eli Lilly & Co. | Mega-cap core · negative news flow | $1.0T | +51.1% | -7.3% | 47.5 | Neutral |
| MRK Merck & Co., Inc. | Mega-cap core · negative news flow | $362B | +80.1% | -1.4% | 55.7 | Underweight |
| KLAC KLA Corporation | Mega-cap core · negative news flow | $231B | +69.1% | -4.8% | 45.9 | Buy |
| AMGN Amgen Inc | Mega-cap core · negative news flow | $208B | +39.8% | -11.1% | 39.9 | Neutral |
| GILD Gilead Sciences Inc | Mega-cap core · negative news flow | $186B | +32.1% | +4.7% | 61.6 | Underweight |
| ABT Abbott Laboratories | Mega-cap core · negative news flow | $178B | -23.7% | -10.1% | 38.1 | Underweight |
| PFE Pfizer Inc. | Mega-cap core · negative news flow | $158B | +14.5% | -0.5% | 51.7 | Neutral |
| DHR Danaher Corporation | Mega-cap core · negative news flow | $149B | +8.5% | -1.9% | 56.9 | Neutral |
| BMY Bristol-Myers Squibb Co. | Mega-cap core · negative news flow | $129B | +38.3% | -3.7% | 41 | Neutral |
| MDT Medtronic plc | Mega-cap core · negative news flow | $118B | -3.6% | -0.2% | 53.6 | Underweight |
| MCK McKesson Corporation | Mega-cap core · negative news flow | $102B | +26.7% | +4.3% | 47.5 | Underweight |
| TT Trane Technologies plc | Mega-cap core · negative news flow | $94B | +6.6% | -4.9% | 37.4 | Underweight |
| MMM 3M Company | Mega-cap core · negative news flow | $86B | +6.8% | -6.8% | 41.8 | Underweight |
| REGN Regeneron Pharmaceuticals Inc | Mega-cap core · negative news flow | $81B | +31.1% | -5.1% | 48 | Underweight |
| COR Cencora, Inc. | Mega-cap core · negative news flow | $59B | +6.2% | -1.9% | 39.6 | Underweight |
| TER Teradyne, Inc. | Mega-cap core · negative news flow | $58B | +212.6% | -3.0% | 52.3 | Buy |
| KEYS Keysight Technologies, Inc. | Mega-cap core · negative news flow | $57B | +89.0% | +5.8% | 54.3 | Buy |
| BDX Becton, Dickinson and Co. | Mega-cap core · negative news flow | $49B | -3.9% | -3.6% | 50.1 | Underweight |
| IQV IQVIA Holdings Inc. | Mega-cap core · negative news flow | $44B | +40.1% | +4.1% | 61.9 | Underweight |
| WAT Waters Corp | Mega-cap core · negative news flow | $41B | +37.6% | +4.2% | 59.1 | Neutral |
| IDXX Idexx Laboratories Inc | Mega-cap core · negative news flow | $40B | -21.9% | -6.3% | 38.3 | Neutral |
| RMD ResMed Inc. | Mega-cap core · negative news flow | $32B | -17.7% | -1.5% | 50.4 | Underweight |
| BIIB Biogen Inc. | Mega-cap core · negative news flow | $32B | +49.9% | +0.5% | 50.6 | Underweight |
| MTD Mettler-Toledo International | Mega-cap core · negative news flow | $28B | +8.2% | -0.1% | 56.7 | Buy |
| DGX Quest Diagnostics Inc. | Mega-cap core · negative news flow | $27B | +34.4% | +2.1% | 63.2 | Neutral |
| LH Labcorp Holdings Inc. | Mega-cap core · negative news flow | $26B | +15.7% | -3.6% | 49.8 | Underweight |
| INCY Incyte Genomics Inc | Mega-cap core · negative news flow | $25B | +45.7% | -1.5% | 52.9 | Underweight |
| VTRS Viatris Inc. | Mega-cap core · negative news flow | $19B | +71.9% | +5.2% | 55.2 | Neutral |
| EHC Encompass Health Corporation | Mega-cap core · negative news flow | $12B | -2.9% | +0.7% | 54 | Underweight |
| UHS Universal Health Services, Inc. | Mega-cap core · negative news flow | $10B | -6.1% | +2.2% | 56.5 | Neutral |
| CGNX Cognex Corp | Mega-cap core · negative news flow | $10B | +33.3% | +3.1% | 49.6 | Neutral |
| MMED MiniMed Group, Inc. | Mega-cap core · negative news flow | $6.1B | 0.0% | +8.0% | 55.5 | Underweight |
| JNJ Johnson & Johnson | Positive news flow · engine favourites | $651B | +55.0% | +1.0% | 55 | Underweight |
| ABBV ABBVIE INC. | Positive news flow · engine favourites | $466B | +18.9% | +0.8% | 59.3 | Buy |
| AZN AstraZeneca PLC | Positive news flow · engine favourites | $258B | +7.8% | +1.0% | 55.2 | Buy |
| TMO Thermo Fisher Scientific, Inc. | Positive news flow · engine favourites | $241B | +35.4% | +3.8% | 67.9 | Buy |
| ISRG Intuitive Surgical Inc. | Positive news flow · engine favourites | $139B | -9.7% | +5.0% | 61.4 | Buy |
| VRTX Vertex Pharmaceuticals Inc | Positive news flow · engine favourites | $129B | +31.3% | -5.9% | 41.5 | Underweight |
| HCA HCA Healthcare, Inc. | Positive news flow · engine favourites | $93B | +6.6% | +5.3% | 58.7 | Neutral |
| AME Ametek, Inc. | Positive news flow · engine favourites | $54B | +25.9% | -0.6% | 48.9 | Buy |
| CAH Cardinal Health, Inc. | Positive news flow · engine favourites | $52B | +50.2% | -1.3% | 36.2 | Neutral |
| EW Edwards Lifesciences Corp | Positive news flow · engine favourites | $51B | +18.4% | -1.7% | 49.2 | Neutral |
| ROK Rockwell Automation, Inc. | Positive news flow · engine favourites | $46B | +19.2% | -3.7% | 40.1 | Neutral |
| A Agilent Technologies Inc. | Positive news flow · engine favourites | $44B | +22.6% | +0.1% | 62.9 | Buy |
| DXCM DexCom, Inc. | Positive news flow · engine favourites | $34B | +17.9% | -1.0% | 58.5 | Buy |
| ALNY Alnylam Pharmaceuticals, Inc. | Positive news flow · engine favourites | $32B | -47.0% | +4.5% | 45.6 | Underweight |
| ROIV Roivant Sciences Ltd. Common Shares | Positive news flow · engine favourites | $29B | +163.6% | +8.0% | 60.4 | Neutral |
| RPRX Royalty Pharma plc | Positive news flow · engine favourites | $26B | +63.5% | -3.6% | 42.3 | Underweight |
| WST West Pharmaceutical Services, Inc. | Positive news flow · engine favourites | $25B | +42.1% | +2.4% | 61.9 | Neutral |
| UTHR United Therapeutics Corp | Positive news flow · engine favourites | $21B | +20.7% | -5.1% | 41.3 | Underweight |
| THC Tenet Healthcare Corporation New | Positive news flow · engine favourites | $21B | +37.7% | -3.9% | 51.4 | Underweight |
| ZBH Zimmer Biomet Holdings, Inc. | Positive news flow · engine favourites | $18B | -4.8% | -3.6% | 46.7 | Buy |
| MEDP Medpace Holdings, Inc. | Positive news flow · engine favourites | $17B | +22.0% | 0.0% | 59.3 | Buy |
| SOLV Solventum Corporation | Positive news flow · engine favourites | $15B | +19.5% | +0.3% | 51.2 | Buy |
| EXEL Exelixis Inc | Positive news flow · engine favourites | $14B | +44.3% | +8.7% | 59.1 | Buy |
| MDGL Madrigal Pharmaceuticals, Inc. | Positive news flow · engine favourites | $12B | +20.6% | +2.4% | 50.2 | Underweight |
| DVA DaVita Inc. | Positive news flow · engine favourites | $12B | +41.2% | +4.9% | 46.4 | Buy |
| TECH Bio-Techne Corp. | Positive news flow · engine favourites | $11B | +36.6% | +0.1% | 64.5 | Neutral |
| BTSG BrightSpring Health Services, Inc. | Positive news flow · engine favourites | $11B | +108.4% | -4.6% | 40.7 | Neutral |
| AXSM Axsome Therapeutics, Inc | Positive news flow · engine favourites | $11B | +75.2% | -0.1% | 46 | Neutral |
| BIO Bio-Rad Laboratories, Inc. | Positive news flow · engine favourites | $10B | +31.4% | 0.0% | 55.6 | Underweight |
| RGEN Repligen Corp | Positive news flow · engine favourites | $10.0B | +42.2% | -1.9% | 59.5 | Neutral |
| RAL Ralliant Corporation | Positive news flow · engine favourites | $7.5B | +55.3% | +6.3% | 56.5 | Buy |
| LNTH Lantheus Holdings, Inc | Positive news flow · engine favourites | $6.6B | +95.0% | +0.3% | 46.6 | Neutral |
| RDNT RadNet, Inc. | Positive news flow · engine favourites | $6.0B | -0.8% | -1.4% | 55.8 | Neutral |
| LGND Ligand Pharmaceuticals Inc. | Positive news flow · engine favourites | $5.7B | +66.9% | -1.4% | 48 | Neutral |
| CRSP CRISPR Therapeutics AG | Positive news flow · engine favourites | $5.5B | -10.1% | -2.7% | 55.4 | Buy |
| SYK Stryker Corporation | Oversold tape · momentum laggards | $106B | -27.2% | -16.0% | 31.5 | Underweight |
| BSX Boston Scientific Corp. | Oversold tape · momentum laggards | $63B | -55.9% | -12.2% | 37.9 | Underweight |
| ROP Roper Technologies, Inc. | Oversold tape · momentum laggards | $37B | -26.8% | -9.2% | 34.9 | Underweight |
| ZTS ZOETIS INC. | Oversold tape · momentum laggards | $30B | -51.5% | -4.8% | 36.7 | Underweight |
| GEHC GE HealthCare Technologies Inc. | Oversold tape · momentum laggards | $29B | -13.3% | -13.4% | 33.4 | Underweight |
| MDLN Medline Inc. | Oversold tape · momentum laggards | $28B | 0.0% | -2.9% | 36.2 | Underweight |
| INSM Insmed, Inc. | Oversold tape · momentum laggards | $26B | -17.7% | -4.1% | 46.3 | Underweight |
| PHG KONINKLIJKE PHILIPS N.V. | Oversold tape · momentum laggards | $24B | -9.5% | -10.2% | 31.2 | Neutral |
| VLTO Veralto Corporation | Oversold tape · momentum laggards | $23B | -11.7% | -5.0% | 43.9 | Underweight |
| STE STERIS plc | Oversold tape · momentum laggards | $20B | -18.1% | -13.0% | 25.8 | Underweight |
| MKSI MKS Inc. | Oversold tape · momentum laggards | $17B | +94.0% | -10.6% | 43.5 | Neutral |
| FTV Fortive Corporation | Oversold tape · momentum laggards | $17B | +12.6% | -7.4% | 36 | Underweight |
| NBIX Neurocrine Biosciences Inc | Oversold tape · momentum laggards | $15B | +0.4% | -4.4% | 33.6 | Underweight |
| TRMB Trimble Inc. | Oversold tape · momentum laggards | $13B | -29.5% | -3.5% | 47.6 | Neutral |
| BBIO BridgeBio Pharma, Inc. | Oversold tape · momentum laggards | $13B | +24.9% | -19.7% | 20.4 | Underweight |
| ULS UL Solutions Inc. | Oversold tape · momentum laggards | $13B | -5.8% | -14.9% | 18 | Underweight |
| PEN Penumbra, Inc. | Oversold tape · momentum laggards | $13B | +23.2% | -1.9% | 39.1 | Underweight |
| BMRN BioMarin Pharmaceuticals Inc | Oversold tape · momentum laggards | $12B | +16.0% | -5.5% | 45.9 | Underweight |
| BAX Baxter International Inc. | Oversold tape · momentum laggards | $12B | -3.8% | -13.7% | 29.1 | Underweight |
| ELAN Elanco Animal Health Incorporated | Oversold tape · momentum laggards | $11B | +17.4% | -4.8% | 36.7 | Underweight |
| COO The Cooper Companies, Inc. | Oversold tape · momentum laggards | $11B | -17.7% | -27.4% | 25.8 | Neutral |
| ALGN Align Technology Inc | Oversold tape · momentum laggards | $10B | +11.3% | -7.1% | 35.6 | Underweight |
| ENSG The Ensign Group, Inc. | Oversold tape · momentum laggards | $10B | +4.1% | -3.3% | 48.1 | Underweight |
| KRYS Krystal Biotech, Inc. | Oversold tape · momentum laggards | $10.0B | +109.6% | -0.1% | 43.2 | Underweight |
| GMED GLOBUS MEDICAL INC | Oversold tape · momentum laggards | $9.9B | +30.5% | -13.5% | 35.4 | Underweight |
| PODD Insulet Corporation | Oversold tape · momentum laggards | $9.8B | -57.8% | -4.3% | 45.6 | Neutral |
| CYTK Cytokinetics Inc. | Oversold tape · momentum laggards | $9.6B | +39.5% | -10.9% | 35.2 | Underweight |
| HSIC Henry Schein Inc | Oversold tape · momentum laggards | $9.5B | +23.8% | -4.1% | 35.8 | Underweight |
| ARWR Arrowhead Research Corporation | Oversold tape · momentum laggards | $9.4B | +111.0% | -24.0% | 25 | Underweight |
| PCVX Vaxcyte, Inc. | Oversold tape · momentum laggards | $8.7B | +78.4% | -5.2% | 44.6 | Underweight |
| IONS Ionis Pharmaceuticals, Inc. | Oversold tape · momentum laggards | $7.4B | -28.0% | -24.4% | 25.6 | Underweight |
| ALKS Alkermes Inc. plc | Oversold tape · momentum laggards | $7.3B | +52.0% | -9.6% | 30.5 | Underweight |
| MSA Mine Safety Incorporated | Oversold tape · momentum laggards | $6.9B | +5.3% | -4.7% | 39.1 | Underweight |
| RYTM Rhythm Pharmaceuticals, Inc. | Oversold tape · momentum laggards | $6.7B | -0.8% | -10.3% | 36.5 | Underweight |
| CHE Chemed Corporation | Oversold tape · momentum laggards | $6.6B | +10.0% | -5.8% | 37.7 | Underweight |
| HIMS Hims & Hers Health, Inc. | Oversold tape · momentum laggards | $6.5B | -50.2% | -12.1% | 45.6 | Underweight |
| ST Sensata Technologies Holding plc | Oversold tape · momentum laggards | $6.1B | +31.8% | +0.1% | 44.4 | Underweight |
| BLCO Bausch + Lomb Corporation | Oversold tape · momentum laggards | $6.0B | +9.6% | -2.0% | 43.2 | Neutral |
| MIRM Mirum Pharmaceuticals, Inc. | Oversold tape · momentum laggards | $6.0B | +21.9% | -5.4% | 37.5 | Underweight |
| SRRK Scholar Rock Holding Corporation | Oversold tape · momentum laggards | $5.7B | +43.6% | -15.6% | 31 | Underweight |
| COGT Cogent Biosciences, Inc. | Oversold tape · momentum laggards | $5.5B | +147.6% | -10.8% | 30.5 | Underweight |
| PTCT PTC Therapeutics, Inc. | Oversold tape · momentum laggards | $5.5B | +4.0% | -7.3% | 36.1 | Underweight |
| COHR Coherent Corp. | Momentum leaders · overbought tape | $62B | +193.7% | +9.4% | 56.1 | Buy |
| MRNA Moderna, Inc. | Momentum leaders · overbought tape | $61B | +505.3% | +15.5% | 63.3 | Neutral |
| NTRA Natera, Inc. | Momentum leaders · overbought tape | $53B | +105.4% | +13.7% | 74.4 | Buy |
| ILMN Illumina Inc | Momentum leaders · overbought tape | $36B | +132.6% | +12.4% | 65.9 | Buy |
| GH Guardant Health, Inc. | Momentum leaders · overbought tape | $24B | +205.1% | +6.9% | 63.3 | Buy |
| RVTY Revvity, Inc. | Momentum leaders · overbought tape | $16B | +63.5% | +15.6% | 69.4 | Buy |
| SMMT Summit Therapeutics Inc. | Momentum leaders · overbought tape | $14B | -7.2% | +43.6% | 64.3 | Buy |
| HALO Halozyme Therapeutics, Inc. | Momentum leaders · overbought tape | $13B | +46.7% | +6.0% | 70.2 | Buy |
| TWST Twist Bioscience Corporation | Momentum leaders · overbought tape | $11B | +497.5% | +22.5% | 73 | Buy |
| AVTR Avantor, Inc. | Momentum leaders · overbought tape | $10B | +20.7% | +8.9% | 64.9 | Neutral |
| TXG 10x Genomics, Inc. | Momentum leaders · overbought tape | $10.0B | +477.2% | +19.9% | 73.7 | Buy |
| BRKR Bruker Corporation | Momentum leaders · overbought tape | $9.4B | +84.5% | +2.5% | 57.7 | Neutral |
| IBRX ImmunityBio, Inc. | Momentum leaders · overbought tape | $9.0B | +197.5% | +8.2% | 58 | Buy |
| TGTX TG Therapeutics, Inc. | Momentum leaders · overbought tape | $8.7B | +74.4% | +12.5% | 59.4 | Buy |
| CAI Caris Life Sciences, Inc. | Momentum leaders · overbought tape | $8.5B | -10.3% | +22.0% | 70.6 | Neutral |
| AMRX Amneal Pharmaceuticals, Inc. | Momentum leaders · overbought tape | $6.5B | +90.7% | +4.5% | 60.9 | Buy |
| RVMD Revolution Medicines, Inc. | Past-year winners · six-month runners | $41B | +322.3% | -9.8% | 36.1 | Underweight |
| JAZZ Jazz Pharmaceuticals, Inc. | Past-year winners · six-month runners | $16B | +83.5% | -3.2% | 43.8 | Underweight |
| CRL Charles River Laboratories International, Inc. | Past-year winners · six-month runners | $13B | +77.1% | -4.6% | 51.7 | Underweight |
| ONTO Onto Innovation Inc. | Past-year winners · six-month runners | $13B | +113.6% | -11.8% | 46.6 | Underweight |
| CORT Corcept Therapeutics Inc. | Past-year winners · six-month runners | $12B | +38.2% | -8.9% | 46.5 | Underweight |
| KYMR Kymera Therapeutics, Inc. | Past-year winners · six-month runners | $9.8B | +130.2% | -3.1% | 53.5 | Underweight |
| GKOS Glaukos Corporation | Past-year winners · six-month runners | $9.7B | +90.8% | -11.4% | 39.8 | Underweight |
| PTGX Protagonist Therapeutics, Inc | Past-year winners · six-month runners | $9.3B | +130.1% | -5.1% | 45.5 | Underweight |
| PRAX Praxis Precision Medicines, Inc. | Past-year winners · six-month runners | $8.3B | +561.0% | -18.0% | 31.1 | Underweight |
| SYRE Spyre Therapeutics, Inc. | Past-year winners · six-month runners | $8.0B | +489.1% | -16.3% | 42.8 | Underweight |
| IMVT Immunovant, Inc. | Past-year winners · six-month runners | $7.6B | +139.9% | -16.7% | 36.3 | Underweight |
| PACS PACS Group, Inc. | Past-year winners · six-month runners | $6.7B | +251.0% | -3.3% | 42 | Underweight |
| CGON CG Oncology, Inc. | Past-year winners · six-month runners | $6.6B | +92.2% | -3.8% | 51 | Underweight |
| ORKA Oruka Therapeutics, Inc. | Past-year winners · six-month runners | $6.3B | +472.7% | -9.4% | 49.2 | Underweight |
| KNSA Kiniksa Pharmaceuticals International, plc | Past-year winners · six-month runners | $6.0B | +115.0% | -1.6% | 51.1 | Underweight |
| LQDA Liquidia Corporation | Past-year winners · six-month runners | $6.0B | +171.1% | -5.9% | 41.1 | Neutral |
| TVTX Travere Therapeutics, Inc. | Past-year winners · six-month runners | $5.9B | +159.5% | -2.6% | 45.6 | Underweight |
Which major wrappers carry this ranking — counted over 18 curated funds (sector SPDRs + broad-market index funds), not every ETF in existence. The full stock ↔ ETF passive-flow map is at Equities Network.
The largest listed healthcare companies by market cap are Eli Lilly & Co. ($1.0T), Johnson & Johnson ($651B), ABBVIE INC. ($466B), Merck & Co., Inc. ($362B), Novartis AG ($267B). The full ranking of 893 stocks refreshes daily at quantlogix.ai/public/healthcare.
Among the top-50 healthcare stocks by market cap, the best 1-year returns are Moderna, Inc. (+505.3%), Revolution Medicines, Inc. (+322.3%), Teradyne, Inc. (+212.6%), measured to 2026-09-18. Past performance does not predict future results.
Among 18 curated major wrappers, the funds holding the most of the top 50 healthcare stocks are IVV (50), SPY (50), VOO (50). Full map: Equities Network.
142 of the top 150 healthcare names are grouped by a seeded k-means over seven daily features (20-day momentum, RSI, the QL composite, 1-year and 6-month return, size, news sentiment) into 5 clusters: Mega-cap core · negative news flow (32); Positive news flow · engine favourites (35); Oversold tape · momentum laggards (42); Momentum leaders · overbought tape (16); Past-year winners · six-month runners (17). The map is a principal-components projection of the same features. Clusters describe the tape today, not a forecast.
Market caps, prices, and day changes come from the daily universe build (last refreshed 2026-09-21 05:30); 1-year returns come from the performance-rankings build (measured to 2026-09-18). A stock without a price or return history says so rather than showing zero.
Methodology. Rankings are by market capitalization from the daily universe build (last refreshed 2026-09-21 05:30) — prices and day changes carry the same stamp, not live quotes. 1-year returns come from the performance-rankings build (measured to 2026-09-18); a stock without return history says so. The QL Signal is the QuantLogix 5-factor composite — an educational read on technical posture, not investment advice. The cluster map groups the ranked names by a deterministic k-means over seven standardized daily features and lays them out by principal components; clusters are named from their centroid's strongest traits and describe the tape today, not a forecast. Every row links to the full stock page with signals, fundamentals, and news.